Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/17/2023 | Apogee Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 08/17/2023 |
08/17/2023 | Apogee Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 100k | $23.60 | $2.4M | | 08/17/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 128.9k | $110.20 | $14.2M | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 246.6k | $29.56 | $7.3M | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 290k | $36.32 | $10.5M | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 566.3k | $6.70 | $3.8M | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 481.7k | $3.70 | $1.8M | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 20k | $3.10 | $62k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 132.7k | $1.70 | $225.7k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Stock Option (right to buy) | 161.1k | $2.90 | $467.2k | | 06/16/2023 |
06/16/2023 | Prometheus Biosciences, Inc. | RXDX | Disposition | Common Stock | 178.1k | $0.00 | $0 | | 06/16/2023 |
06/02/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 3 | $1.70 | $5.1 | | 06/02/2023 |
06/02/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 122.5k | $2.90 | $355.3k | | 06/02/2023 |
03/15/2023 | Prometheus Biosciences, Inc. | RXDX | Sale | Common Stock | 25k | $116.14 | $2.9M | | 03/15/2023 |
03/15/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 25k | $2.90 | $72.5k | | 03/15/2023 |
03/03/2023 | Prometheus Biosciences, Inc. | RXDX | Sale | Common Stock | 10.6k | $125.13 | $1.3M | | 03/01/2023 |
03/03/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 10.6k | $3.70 | $39.3k | | 03/01/2023 |
03/01/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 700 | $3.70 | $2.6k | | 03/01/2023 |
03/01/2023 | Prometheus Biosciences, Inc. | RXDX | Sale | Common Stock | 700 | $125.26 | $87.7k | | 03/01/2023 |
01/17/2023 | Prometheus Biosciences, Inc. | RXDX | Sale | Common Stock | 25k | $118.99 | $3M | | 01/17/2023 |
01/17/2023 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 25k | $2.90 | $72.5k | | 01/17/2023 |
12/09/2022 | Prometheus Biosciences, Inc. | RXDX | Grant | Common Stock | 37.1k | $0.00 | $0 | | 12/09/2022 |
12/09/2022 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Options (Right to Buy) | 128.9k | $110.20 | $14.2M | | 12/09/2022 |
05/20/2022 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 246.6k | $29.56 | $7.3M | | 05/20/2022 |
12/01/2021 | Prometheus Biosciences, Inc. | RXDX | Exercise | Stock Option (Right to Buy) | 15.4k | $2.90 | $44.7k | | 12/01/2021 |
11/14/2021 | Prometheus Biosciences, Inc. | RXDX | Grant | Stock Option (Right to Buy) | 290k | $36.32 | $10.5M | | 11/14/2021 |
08/19/2019 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 10.8k | $21.83 | $235.2k | | 08/19/2019 |
06/24/2019 | Bausch Health Companies Inc. | BHC | Payment of Exercise | Common Shares, No Par Value | 1.9k | $23.82 | $45.6k | | 06/24/2019 |
05/06/2019 | Bausch Health Companies Inc. | BHC | Payment of Exercise | Common Shares, No Par Value | 746 | $23.51 | $17.5k | | 05/06/2019 |
03/08/2019 | Bausch Health Companies Inc. | BHC | Payment of Exercise | Common Shares, No Par Value | 974 | $23.56 | $22.9k | | 03/08/2019 |
02/27/2019 | Bausch Health Companies Inc. | BHC | Grant | Common Shares, No Par Value | 15.2k | $0.00 | $0 | | 02/27/2019 |
02/27/2019 | Bausch Health Companies Inc. | BHC | Grant | Non-qualified Stock Options (right To Purchase) | 44.3k | $23.16 | $1M | | 02/27/2019 |
01/08/2019 | Bausch Health Companies Inc. | BHC | Payment of Exercise | Common Shares, No Par Value | 1.2k | $21.25 | $25.3k | | 01/08/2019 |